Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purging CTCs in Metastatic Breast Cancer
NCT00429182Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2007
- Primary completion
- Feb 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label trial of carboplatin, cyclophosphamide and thiotepa in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2007; status: completed.
02
Drugs
carboplatincyclophosphamidethiotepa
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00429182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429182.